Blutdruckmanagement beim akuten Schlaganfall (Ischämie, Blutung, SAB)

Joji B. Kuramatsu; Hagen B. Huttner; Stefan Schwab

doi:10.1055/a-0657-7643

Neurologie up2date, Table of Contents

Neurologie up2date 2018; 1(01): 27-44
DOI: 10.1055/a-0657-7643

Zerebrovaskuläre Erkrankungen

Georg Thieme Verlag KG Stuttgart · New York

Blutdruckmanagement beim akuten Schlaganfall (Ischämie, Blutung, SAB)

Joji B. Kuramatsu

,

Hagen B. Huttner

,

Stefan Schwab

Abstract

All articles of this category

Ziel dieses Übersichtsartikels ist es, die aktuelle Datenlage zur Blutdruckbehandlung im Rahmen eines akuten Schlaganfalls – ischämischer Schlaganfall, intrazerebrale Blutung und Subarachnoidalblutung – darzustellen sowie Herausforderungen und Probleme zu diskutieren und mögliche Therapiestrategien aufzuzeigen.

Schlüsselwörter

Blutdruck - ischämischer Schlaganfall - intrazerebrale Blutung - Subarachnoidalblutung - ischämischer Insult - Apoplex - Hirnschlag - Gehirninfarkt

Full Text

References

Literatur
1 MacMahon S, Peto R, Cutler J. et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774
2 Kearney PM, Whelton M, Reynolds K. et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223
3 Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke 1986; 17: 861-864
4 Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 2004; 43: 18-24
5 Leonardi-Bee J, Bath PM, Phillips SJ. et al. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002; 33: 1315-1320
6 Bangalore S, Schwamm L, Smith EE. et al. Blood pressure and in-hospital outcomes in patients presenting with ischaemic stroke. Eur Heart J 2017; 38: 2827-2835
7 Sare GM, Ali M, Shuaib A. et al. Relationship between hyperacute blood pressure and outcome after ischemic stroke: data from the VISTA collaboration. Stroke 2009; 40: 2098-2103
8 Geeganage C, Tracy M, England T. et al. Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke 2011; 42: 491-493
9 Manning L, Hirakawa Y, Arima H. et al. Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial. Lancet Neurol 2014; 13: 364-373
10 Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation 2008; 118: 176-187
11 Chamorro A, Amaro S, Vargas M. et al. Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci 2007; 252: 29-35
12 Xiong L, Liu X, Shang T. et al. Impaired cerebral autoregulation: measurement and application to stroke. J Neurol Neurosurg Psychiat 2017; 88: 520-531
13 Regenhardt RW, Das AS, Stapleton CJ. et al. Blood pressure and penumbral sustenance in stroke from large vessel occlusion. Frontiers Neurol 2017; 8: 317
14 Wang A, Ortega-Gutierrez S, Petersen NH. Autoregulation in the Neuro ICU. Curr Treatment Options Neurol 2018; 20: 20
15 Hamner JW, Tan CO. Relative contributions of sympathetic, cholinergic, and myogenic mechanisms to cerebral autoregulation. Stroke 2014; 45: 1771-1777
16 Tikhonoff V, Zhang H, Richart T. et al. Blood pressure as a prognostic factor after acute stroke. Lancet Neurol 2009; 8: 938-948
17 Wahlgren NG, Macmahon DG, Dekeyser J. et al. Intravenous Nimodipine West-European Stroke Trial (Inwest) of nimodipine in the treatment of acute ischemic stroke. Cerebrovasc Dis 1994; 4: 204-210
18 Horn J, de Haan RJ, Vermeulen M. et al. Very early nimodipine use in stroke (VENUS) – A randomized, double-blind, placebo-controlled trial. Stroke 2001; 32: 461-465
19 He J, Zhang Y, Xu T. et al. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. JAMA 2014; 311: 479-489
20 Xu T, Zhang Y, Bu X. et al. Blood pressure reduction in acute ischemic stroke according to time to treatment: a subgroup analysis of the China Antihypertensive Trial in Acute Ischemic Stroke trial. Curr Hypertens 2017; 35: 1244-1251
21 Sandset EC, Bath PM, Boysen G. et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011; 377: 741-750
22 Jusufovic M, Sandset EC, Bath PM. et al. Early blood pressure lowering treatment in acute stroke. Ordinal analysis of vascular events in the Scandinavian Candesartan Acute Stroke Trial (SCAST). Curr Hypertens 2016; 34: 1594-1598
23 Krishnan K, Scutt P, Woodhouse L. et al. Glyceryl trinitrate for acute intracerebral hemorrhage: results from the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a subgroup analysis. Stroke 2016; 47: 44-52
24 Woodhouse L, Scutt P, Krishnan K. et al. Effect of hyperacute administration (within 6 hours) of transdermal glyceryl trinitrate, a nitric oxide donor, on outcome after stroke: subgroup analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) trial. Stroke 2015; 46: 3194-3201
25 Bath PM, Krishnan K. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev 2014; (10) CD000039
26 Lee M, Ovbiagele B, Hong KS. et al. Effect of Blood pressure lowering in early ischemic stroke: meta-analysis. Stroke 2015; 46: 1883-1889
27 Powers WJ, Rabinstein AA, Ackerson T. et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018; 49: e46-e110
28 Martins AI, Sargento-Freitas J, Silva F. et al. Recanalization modulates association between blood pressure and functional outcome in acute ischemic stroke. Stroke 2016; 47: 1571-1576
29 Vemmos KN, Tsivgoulis G, Spengos K. et al. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med 2004; 255: 257-265
30 Brott T, Lu M, Kothari R. et al. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke 1998; 29: 1504-1509
31 Ahmed N, Wahlgren N, Brainin M. et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). Stroke 2009; 40: 2442-2449
32 Wu W, Huo X, Zhao X. et al. Relationship between blood pressure and outcomes in acute ischemic stroke patients administered lytic medication in the TIMS-China Study. PloS One 2016; 11: e0144260
33 Berge E, Cohen G, Lindley RI. et al. Effects of blood pressure and blood pressure-lowering treatment during the first 24 hours among patients in the third international stroke trial of thrombolytic treatment for acute ischemic stroke. Stroke 2015; 46: 3362-3369
34 Dirks M, Zonneveld TP, Dippel DW. et al. Elevated pretreatment blood pressure and IV thrombolysis in stroke. Neurology 2015; 84: 1419-1425
35 Haverkamp C, Ganslandt T, Horki P. et al. Regional Differences in Thrombectomy Rates : Secondary use of Billing Codes in the MIRACUM (Medical Informatics for Research and Care in University Medicine) Consortium. Clin Neuroradiol 2018; 28: 225-234
36 Goyal M, Menon BK, van Zwam WH. et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016; 387: 1723-1731
37 Maier B, Gory B, Taylor G. et al. Mortality and disability according to baseline blood pressure in acute ischemic stroke patients treated by thrombectomy: a collaborative pooled analysis. J Am Heart Assoc 2017; 6: e006484
38 Goyal N, Tsivgoulis G, Pandhi A. et al. Blood pressure levels post mechanical thrombectomy and outcomes in non-recanalized large vessel occlusion patients. J Neurointerv Surg 2018; 10: 925-931
39 Goyal N, Tsivgoulis G, Pandhi A. et al. Blood pressure levels post mechanical thrombectomy and outcomes in large vessel occlusion strokes. Neurology 2017; 89: 540-547
40 Abou-Chebl A, Yeatts SD, Yan B. et al. Impact of general anesthesia on safety and outcomes in the endovascular arm of Interventional Management of Stroke (IMS) III Trial. Stroke 2015; 46: 2142-2148
41 Berkhemer OA, van den Berg LA, Fransen PS. et al. The effect of anesthetic management during intra-arterial therapy for acute stroke in MR CLEAN. Neurology 2016; 87: 656-664
42 Schonenberger S, Uhlmann L, Hacke W. et al. Effect of conscious sedation vs. general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: a randomized clinical trial. JAMA 2016; 316: 1986-1996
43 Schonenberger S, Uhlmann L, Ungerer M. et al. Association of blood pressure with short- and long-term functional outcome after stroke thrombectomy: post hoc analysis of the SIESTA Trial. Stroke 2018; 49: 1451-1456
44 Simonsen CZ, Yoo AJ, Sorensen LH. et al. Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke: a randomized clinical trial. JAMA Neurol 2018; 75: 470-477
45 Simonsen CZ, Sorensen LH, Juul N. et al. Anesthetic strategy during endovascular therapy: General anesthesia or conscious sedation? (GOLIATH – General or Local Anesthesia in Intra Arterial Therapy) A single-center randomized trial. Int J Stroke 2016; 11: 1045-1052
46 Lowhagen Henden P, Rentzos A, Karlsson JE. et al. General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke: The AnStroke Trial (Anesthesia During Stroke). Stroke 2017; 48: 1601-1607
47 Jagani M, Brinjikji W, Rabinstein AA. et al. Hemodynamics during anesthesia for intra-arterial therapy of acute ischemic stroke. J Neurointerv Surg 2016; 8: 883-888
48 Treurniet KM, Berkhemer OA, Immink RV. et al. A decrease in blood pressure is associated with unfavorable outcome in patients undergoing thrombectomy under general anesthesia. J Neurointerv Surg 2018; 10: 107-111
49 Mistry EA, Mistry AM, Nakawah MO. et al. Systolic blood pressure within 24 hours after thrombectomy for acute ischemic stroke correlates with outcome. J Am Heart Assoc 2017; 6: pii:e006167
50 Mulder M, Ergezen S, Lingsma HF. et al. Baseline blood pressure effect on the benefit and safety of intra-arterial treatment in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands). Stroke 2017; 48: 1869-1876
51 Maier B, Gory B, Taylor G. et al. Mortality and disability according to baseline blood pressure in acute ischemic stroke patients treated by thrombectomy: a collaborative pooled analysis. J Am Heart Assoc 2017; 6: e006484
52 Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet 2009; 373: 1632-1644
53 Krishnamurthi RV, Feigin VL, Forouzanfar MH. et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet Global Health 2013; 1: e259-e281
54 Flaherty ML, Kissela B, Woo D. et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 2007; 68: 116-121
55 Liotta EM, Prabhakaran S. Warfarin-associated Intracerebral hemorrhage is increasing in prevalence in the United States. J Stroke Cerebrovasc 2013; 22: 1151-1155
56 Morotti A, Brouwers HB, Romero JM. et al. Intensive blood pressure reduction and spot sign in intracerebral hemorrhage: a secondary analysis of a randomized clinical trial. JAMA Neurol 2017; 74: 950-960
57 Morotti A, Dowlatshahi D, Boulouis G. et al. Predicting intracerebral hemorrhage expansion with noncontrast computed tomography: The BAT score. Stroke 2018; 49: 1163-1169
58 Wang X, Arima H, Al-Shahi Salman R. et al. Clinical prediction algorithm (BRAIN) to determine risk of hematoma growth in acute intracerebral hemorrhage. Stroke 2015; 46: 376-381
59 Anderson CS, Heeley E, Huang Y. et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. New Engl J Med 2013; 368: 2355-2365
60 Qureshi AI, Palesch YY, Barsan WG. et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. New Engl J Med 2016; 375: 1033-1043
61 Boulouis G, Morotti A, Goldstein JN. et al. Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials. J Neurol Neurosurg Psychiat 2017; 88: 339-345
62 Tsivgoulis G, Katsanos AH, Butcher KS. et al. Intensive blood pressure reduction in acute intracerebral hemorrhage: a meta-analysis. Neurology 2014; 83: 1523-1529
63 Arima H, Heeley E, Delcourt C. et al. Optimal achieved blood pressure in acute intracerebral hemorrhage: INTERACT2. Neurology 2015; 84: 464-471
64 Kuramatsu JB, Gerner ST, Schellinger PD. et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA 2015; 313: 824-836
65 Kuramatsu JB, Sembill JA, Gerner ST. et al. Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves. Eur Heart J 2018; 39: 1709-1723
66 Gerner ST, Kuramatsu JB, Sembill JA. et al. Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage. Ann Neurol 2018; 83: 186-196
67 Rinkel GJE, Algra A. Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol 2011; 10: 349-356
68 Lawton MT, Vates GE. Subarachnoid hemorrhage. New Engl J Med 2017; 377: 257-266
69 Lovelock CE, Rinkel GJE, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review. Neurology 2010; 74: 1494-1501
70 Nieuwkamp DJ, Setz LE, Algra A. et al. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 2009; 8: 635-642
71 Vergouwen MD, Jong-Tjien-Fa AV, Algra A. et al. Time trends in causes of death after aneurysmal subarachnoid hemorrhage: A hospital-based study. Neurology 2016; 86: 59-63
72 Grasso G, Alafaci C, Macdonald RL. Management of aneurysmal subarachnoid hemorrhage: State of the art and future perspectives. Surg Neurol Int 2017; 8: 11
73 Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nature Rev Neurol 2014; 10: 44-58
74 Tang C, Zhang TS, Zhou LF. Risk factors for rebleeding of aneurysmal subarachnoid hemorrhage: a meta-analysis. PloS One 2014; 9: e99536
75 Lin QS, Ping C, Lin YX. et al. Systolic blood pressure variability is a novel risk factor for rebleeding in acute subarachnoid hemorrhage: a case-control study. Medicine 2016; 95: e3028
76 Oheda M, Inamasu J, Moriya S. et al. Early rebleeding in patients with subarachnoid haemorrhage under intensive blood pressure management. J Clin Neurosci 2015; 22: 1338-1342
77 Cai K, Zhang Y, Shen L. et al. Characteristics of blood pressure profiles after endovascular coiling as predictors of clinical outcome in poor-grade aneurysmal subarachnoid hemorrhage. World Neurosurg 2017; 104: 459-466
78 Gathier CS, Dankbaar JW, van der Jagt M. et al. Effects of induced hypertension on cerebral perfusion in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke 2015; 46: 3277-3281
79 Gathier CS, van den Bergh WM, van der Jagt M. et al. Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke 2018; 49: 76-83
80 Lisk DR, Grotta JC, Lamki LM. et al. Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Arch Neurol 1993; 50: 855-862
81 Yang W, Zhou YJ, Fu Y. et al. A multicenter, randomized, trial comparing urapidil and nitroglycerin in multifactor heart failure in the elderly. Am J Med Sci 2015; 350: 109-115
82 Potter JF, Robinson TG, Ford GA. et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol 2009; 8: 48-56
83 Eveson DJ, Robinson TG, Potter JF. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up. Am J Hypertens 2007; 20: 270-277
84 Dyker AG, Grosset DG, Lees K. Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke. Stroke 1997; 28: 580-583
85 Schrader J, Luders S, Kulschewski A. et al. The ACCESS study – Evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 2003; 34: 1699-1703
86 Bath PMW, Martin RH, Palesch Y. et al. Effect of Telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke. A PRoFESS Subgroup Analysis. Stroke 2009; 40: 3541-3546
87 Oh MS, Yu KH, Hong KS. et al. Modest blood pressure reduction with valsartan in acute ischemic stroke: a prospective, randomized, open-label, blinded-end-point trial. Int J Stroke 2015; 10: 745-751
88 Barer DH, Cruickshank JM, Ebrahim SB. et al. Low dose beta blockade in acute stroke ("BEST" trial): an evaluation. Br Med J (Clin Res Ed) 1988; 296: 737-741
89 Horn J, Limburg M. Calcium antagonists for ischemic stroke: a systematic review. Stroke 2001; 32: 570-576
90 Rashid P, Weaver C, Leonardi-Bee J. et al. The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. J Stroke Cerebrovasc Dis 2003; 12: 143-151
91 Willmot M, Ghadami A, Whysall B. et al. Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension 2006; 47: 1209-1215
92 Bath PMW, Woodhouse L, Scutt P. et al. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet 2015; 385: 617-628